Gynaecologic Oncology Society of Kenya (GOSK) clinical management protocol for vulvar cancer in Kenya: 2026

Authors

  • Dr. Isaac M. Muchiri Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Victor T. Otieno Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Francis O. Abinya Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Prof. Rose J. Kosgei Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Alfred Mokomba Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Wycliffe Musalia Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Millicent S. Masinde Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Benjamin E. Odongo Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Prof. Jacqueline J. Chesang' Department of Public and Global Health, University of Nairobi, Nairobi, Kenya
  • Dr. Bruce O. Semo Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta University, Nairobi, Kenya
  • Dr. Steven M. Ibua Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Margaret K. Kilonzo Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Prof. Eunice J. Cheserem Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Naomi N. Sitati Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Anwar Z. Mohamed Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Stella N. Njenga Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Diana Marion Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Gideon M. Mutua Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Simon M. Gitau Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya
  • Dr. Innocent O. Maranga Department of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya; Department of Obstetrics and Gynecology, Kenyatta National Hospital, Nairobi, Kenya; School of Medical Sciences, Amref International University, Nairobi, Kenya

DOI:

https://doi.org/10.59692/mgts7007

Keywords:

Kenya, Vulvar cancer, Vulvar melanoma, Vulvar sarcoma

Abstract

Objective: To develop a standardized, evidence-based clinical management protocol for vulvar cancer in Kenya through adaptation and contextualization of relevant international clinical practice guidelines.

Methods: The protocol was developed using a guideline adaptation approach to align recommendations from high-quality international clinical practice guidelines with Kenya’s healthcare system and resource context. A multidisciplinary development panel comprising gynecologic oncologists, pathologists, radiologists, oncology nurses, pharmacists, radiation oncologists, public health specialists, and patient representatives participated in the process. Panel members received technical training from the University of Nairobi and Kenyatta National Hospital on evidence-based guideline adaptation, including standardized appraisal, systematic evaluation of guidelines, and contextualization to local realities. A systematic search of PubMed and Google Scholar was conducted to identify relevant clinical practice guidelines and supporting evidence. Five guidelines were identified and independently appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Three guidelines were selected as source guidelines for adaptation: the British Gynaecological Cancer Society (BGCS) Vulval Cancer Guidelines, the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Vulvar Cancer, and the European Society of Gynaecological Oncology (ESGO) Guidelines for the Management of Vulvar Cancer. The selected guidelines were reviewed and their recommendations adapted and contextualized to the Kenyan healthcare setting.

Results: The resulting protocol addresses the diagnosis, referral, staging, pathology, pre-operative assessment, surgical management, and treatment of vulvar cancer, including local and groin management, sentinel lymph node procedures, reconstructive surgery, chemotherapy, radiotherapy, and systemic therapy. It also addresses the management of recurrent disease at vulvar, inguinal, pelvic, and distant sites, follow-up and survivorship, supportive and palliative care, and selected histological subtypes and clinical circumstances.

Recommendations: The protocol provides evidence-based recommendations for the diagnosis, stage- and histology-specific management, surveillance, and management of recurrent vulvar cancer, contextualized to the Kenyan healthcare and resource setting. It also supports multidisciplinary care, appropriate referral, consideration of clinical trials, and access to emerging treatment approaches where clinically appropriate and available.

References

1. Faber MT, Sand FL, Albieri V, Norrild B, Kjaer SK, Verdoodt F. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva. Int J cancer. 2017 Sep;141(6):1161–9.

2. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021;149(4):778–89.

3. Bucchi L, Pizzato M, Rosso S, Ferretti S. New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors. Cancers (Basel). 2022 Jan;14(2).

4. vulva @ seer.cancer.gov [Internet]. Available from: https://seer.cancer.gov/statfacts/html/vulva.html

5. Ninimiya SY, Ansu-Mensah M, Bawontuo V, Kuupiel D. Mapping evidence on ovarian, endometrial, vaginal, and vulva cancer research in Africa: a scoping review protocol. Syst Rev [Internet]. 2021;10(1):108. Available from: https://doi.org/10.1186/s13643-021-01654-0

6. No Title. Zhang, J, Zhang, Y Zhang, Z (2018) Preval Hum papillomavirus its Progn value vulvar cancer A Syst Rev meta-analysis PLoS One 13(9) https//doi.org/101371/journal.pone0204162.

7. Abu-Rustum, N. R., Yashar, C. M., Arend, R., Barber, E., Bradley, K., Brooks, R., Campos, S. M., Chino, J., Chon, H. S., Crispens, M. A., Damast, S., Fisher, C. M., Frederick, P., Gaffney, D. K., Gaillard, S., II, R. G., Glaser, S., Holmes, J., Howitt, B. pp. 117 135. https://doi. org/10. 6004/jnccn. 2024. 001. No Title.

8. Dryden SM, Reshko LB, Gaskins JT, Silva SR. Verrucous carcinoma of the vulva: Patterns of care and treatment outcomes. Cancer reports (Hoboken, NJ). 2022 Oct;5(10):e21591.

Downloads

Published

2026-11-17

How to Cite

Gynaecologic Oncology Society of Kenya (GOSK) clinical management protocol for vulvar cancer in Kenya: 2026. (2026). Journal of Obstetrics and Gynaecology of Eastern and Central Africa, 38(3). https://doi.org/10.59692/mgts7007

Similar Articles

51-60 of 165

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

1 2 3 > >>